At the news
? NEUTRALIMPACT 3/10 8-K filed Apr 14, 2026 at 06:45 ET
LeMaitre Vascular announced director Bridget Ross will not stand for re-election at the 2026 Annual Meeting, and the board nominated David B. Roberts to fill the Class II seat. Concurrently, the company reduced its board size from eight to seven members effective upon Ross's departure. These changes are part of a board rebalancing effort with no indication of operational disagreements.
- Director Bridget Ross notified the board on April 8, 2026, of her decision not to stand for re-election at the 2026 Annual Meeting.
- David B. Roberts was nominated to stand for election as a Class II director, contingent on his conditional resignation as a Class I director.
- The board size is being reduced from eight to seven members effective upon Ross's departure.
- The company stated Ross's decision is not related to any disagreement with the company.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access